MATTHEW BOTEIN 

Managing Director, Chief Investment Officer and Global Co-Head of BlackRock Alternative Investors; Alignment Artist Capital Director

Matthew Botein, Managing Director, is global co-head and Chief Investment Officer of BlackRock Alternative Investors (BAI), serves as a member of BlackRock's Global Operating Committee and leads BlackRock Private Markets. BAI includes BlackRock's hedge funds and opportunistic funds, funds of hedge funds, private equity, private equity funds of funds, real estate, and real assets.

Prior to joining BlackRock in 2009, Mr. Botein was a Managing Director and member of the Management Committee at Highfields Capital Management, a Boston-based private investment partnership. At Highfields, he was responsible for a portfolio of financial services investments, as well as certain other private equity holdings. Previously, he was a member of the private equity departments at The Blackstone Group and Lazard Freres & Co. LLC.

Mr. Botein serves on numerous boards, including PennyMac Financial Services (NYSE: PFSI), Northeast Bancorp (NASDAQ: NBN) and Alliance Partners LLC. He previously served on the boards of Aspen Insurance Holdings Limited (NYSE: AHL), First American Corporation (NYSE: FAF), PennyMac Mortgage Investment Trust (NYSE: PMT) and CoreLogic Inc. (NYSE: CLGX). He also serves on the Board of Trustees of Beth Israel Deaconess Medical Center, the CareGroup/CJP Board of Managers and the Exceptional Care Without Exception Trust of Boston Medical Center.

Mr. Botein earned an AB degree, Phi Beta Kappa, magna cum laude, from Harvard College and an MBA degree, with high distinction, from Harvard Business School, where he was a Baker Scholar and a Loeb Scholar.